La chaîne d'options affiche les données clés des options sur actions de CNFinance Hldgs à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour CNFinance Hldgs..

CNFinance Hldgs (NYSE:CNF) Stock, Chaîne d'Options

CNFinance Hldgs

CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.

CNFinance Holdings Limited American Depositary Shares, each representing twenty (20) Ordinary Shares

CNFinance Holdings Ltd

CANAFARMA HEMP PRODS by CANAFARMA HEMP PRODS CORP.

CanaFarma Hemp Products Corp

CHINA NONFERROUS MNING CP by China Nonferrous Mining Corp Ltd.

China Nonferrous Mining Corp Ltd

CFN ENTERPRISES INC by CFN ENTERPRISES INC.

CFN Enterprises Inc

Conifer Holdings Inc

Conifer Holdings, Inc. - 9.75% Senior Unsecured Notes due 2028

DA Davidson analyst Wyatt Swanson maintains Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) with a Buy and raises the price target from $250 to $270.

News

Price Target

Analyst Ratings

TTWO

DA Davidson Maintains Buy on Take-Two Interactive, Raises Price Target to $270

Sen. Elizabeth Warren lit up X just after midnight Friday, accusing Elon Musk, Vice President JD Vance and President Donald Trump of "lying about Social Security fraud" and pointing to internal Social Security Administration files that found "no significant fraud".
What Happened: "This is a HUGE scandal. Elon Musk, JD Vance, and Trump are lying about Social Security fraud. Internal documents show DOGE found ‘no significant fraud' — but did slow retirement claim processing by 25%. Nothing efficient about making it harder for people to get their benefits," Warren wrote on X.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is a HUGE scandal. Elon Musk, JD Vance, and Trump are lying about Social Security fraud. Internal documents show DOGE found &quot;no significant fraud&quot;—but did slow retirement claim processing by 25%. Nothing efficient about making it harder for people to get their benefits. <a href="https://t.co/zfWwMWYNHq">https://t.co/zfWwMWYNHq</a>
&mdash; Elizabeth Warren (@SenWarren) <a href="https://twitter.com/SenWarren/status/1923109089447465192?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Warren was referring to a May 15 briefing <a href="https://www.nextgov.com/digital-government/2025/05/doge-went-looking-phone-fraud-ssa-and-found-almost-none/405346/">obtained</a> by Nextgov that reveals the Department of Government Efficiency (DOGE) flagged just two suspicious phone-based benefit changes out of more than 110,000 calls — an effective fraud rate of 0.0018 percent. Auditors concluded "no significant fraud has been detected," but the extra screening stretched average claim-processing times by roughly one-quarter.
See also: <a href="https://www.benzinga.com/25/05/45464834/apple-iphone-production-in-us-not-feasible-says-tech-bull-after-donald-trump-tells-tim-cook-to-stay-out-of-india">Apple iPhone Production In US &#8216;Not Feasible,&#8217; Says Tech Bull After Donald Trump Tells Tim Cook To Stay Out Of India</a>
Vance told Fox viewers last month that "40 percent" of Social Security calls were fraudulent, a statement the Washington Post <a href="https://www.washingtonpost.com/politics/2025/04/08/vance-social-security-fraud-false/">awarded</a> Four Pinocchios. Trump, in a March address to Congress, repeated a debunked claim that checks were going to "people 150 years old," according to an <a href="https://www.wsj.com/livecoverage/trump-speech-congress-joint-session/card/trump-s-social-security-claims-far-overstate-payments-to-150-year-olds-TSkJUEaopsligDh9ElS7">account</a> by WSJ. Musk amplified similar rumors on X, <a href="https://www.benzinga.com/news/25/02/43774570/elon-musk-sparks-debate-on-social-security-data-after-report-finds-millions-of-alive-centenarians-in-america">joking about</a> "vampires collecting Social Security." Independent tallies by the Center on Budget and Policy Priorities show less than 0.01 percent of last year's $1.5 trillion payout was lost to direct-deposit fraud.
Why It Matters: Musk has <a href="https://www.nextgov.com/digital-government/2025/05/doge-went-looking-phone-fraud-ssa-and-found-almost-none/405346/">previously insisted</a> that the fraud "could be billions" and cited DOGE's ongoing probe. The Social Security Administration noted its databases "<a href="https://www.benzinga.com/25/04/44769836/the-social-security-administration-claps-back-at-musk-the-agencys-records-are-highly-accurate">are highly accurate</a>" and that aging record glitches rarely translate into real payments.
Warren&#8217;s post on X also arrives after CBS and Axios reported that the House GOP's tax package would wipe out <a href="https://www.cbsnews.com/news/trump-tax-cuts-overtime-social-security-senior-deduction/">federal levies on tips and overtime</a> pay and slash the corporate rate to <a href="https://www.axios.com/2025/05/05/trump-taxes-congress">15 percent</a> for U.S. manufacturers, delivering on several of Donald Trump's marquee campaign pledges. However, it drops <a href="https://www.benzinga.com/general/health-care/25/05/45431505/gop-tax-bill-breaks-trumps-social-security-tax-pledge-still-hits-25-million-seniors-while-elon-musks-stock-wealth-skirts-fica">his separate promise</a> to exempt Social Security benefits from income tax, substituting instead a smaller $4,000 deduction for seniors.
Photo: OogImages/Shutterstock
Read next: <a href="https://www.benzinga.com/media/25/05/45463922/satya-nadella-once-bet-big-on-chatgpt-maker-openai-now-hes-reportedly-embracing-rivals-like-deepseek-and-building-cheaper-ai-models-to-future-proof-microsoft">Satya Nadella Once Bet Big On ChatGPT-Maker OpenAI — Now He&#8217;s Reportedly Embracing Rivals Like DeepSeek And Building Cheaper AI Models To Future-Proof Microsoft</a>

Government

Regulations

Personal Finance

Elizabeth Warren Torches DOGE's Social Security Fraud Claims Pointing At Internal Memo Discovery, Says 'Elon Musk, JD Vance, And Trump Are Lying'

Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) said on Thursday that it will construct nine new <a target="_blank" href="https://www.benzinga.com/topic/tsmc" rel="noreferrer noopener">advanced wafer manufacturing</a> and packaging factories by 2025.
It plans to build nine new factories, including eight wafer fabrication plants and one advanced chip packaging factory, the Taipei Times <a target="_blank" href="https://www.taipeitimes.com/News/front/archives/2025/05/16/2003836967" rel="noreferrer noopener">reported</a> on Friday, citing Taiwan Semiconductor vice president T.S. Chang at the company&#8217;s annual technology symposium.
TSMC expects to see 60% year-over-year growth in shipments for chips made with the 3-nanometer process.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/25/05/45352452/why-are-nvidia-and-other-chip-stocks-trading-higher-on-monday" rel="noreferrer noopener">Nvidia, Chip Stocks Jump as U.S.-China Agree to Slash Tariffs in Surprise Trade Truce</a>
The company told the Taipei Times that it expects shipments of overall AI chips to grow 12X this year compared to 2021, with Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) as one of the biggest customers.
According to the report, the Taiwanese chipmaker built an average of five factories annually from 2021 to 2024 and three from 2017 to 2020.
Taiwan Semiconductor had <a target="_blank" href="https://www.benzinga.com/25/05/45411148/taiwan-semiconductor-commits-15-billion-to-chip-expansion-approves-dividend-amid-rising-global-demand" rel="noreferrer noopener">announced on Tuesday</a> that its board of directors approved $15.25 billion in&nbsp;capital appropriations for&nbsp;long-term expansion to meet growing demand.
The funds will help to&nbsp;install advanced technology&nbsp;and packaging capacity, expand mature and specialty technology, and construct fabs with facility systems.
TSM surged 28% in the last 12 months, backed by demand for its chips from Nvidia and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>).
The contract chipmaker plans to start constructing its most advanced wafer fab in Taichung by the end of 2025.
Taiwan Semiconductor plans to build five wafer fabs to produce 2-nanometer and A16 technology process chips in Kaohsiung. It expects its 2-nanometer technology to start commercializing in the second half of 2025 at two new fabs in Hsinchu and Kaohsiung.
The company will also add an advanced chip packaging facility using chip-on-wafer-on-substrate (CoWoS) technology.
Taiwan Semiconductor expects to expand its CoWoS capacity at a compound annual growth rate of 80% from 2022 to 2026, topping its previous estimate of 60% last year.
Taiwan Semiconductor on Thursday reiterated that total global semiconductor industry revenue would grow 10% annually this year.
Price Action:&nbsp;TSM stock is up 0.27% to $194.75 premarket at the last check on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/media/25/05/45456613/intel-cfo-says-new-chip-output-for-clients-will-be-minimal-eyes-foundry-breakeven-by-2027" target="_blank" rel="noreferrer noopener">Intel CFO Says New Chip Output For Clients Will Be Minimal, Eyes Foundry Breakeven By 2027</a></li>
</ul>
Photo by Jack Hong via Shutterstock

Asia

Tech

Media

AAPL

NVDA

To Serve Exploding AI Chip Demand, Taiwan Semiconductor Plans 9 Advanced Factories

Canaccord Genuity analyst Whitney Ijem maintains Taysha Gene Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSHA#NASDAQ">TSHA</a>) with a Buy and raises the price target from $8 to $9.

TSHA

Canaccord Genuity Maintains Buy on Taysha Gene Therapies, Raises Price Target to $9

As part of his ongoing Middle East tour, President Donald Trump addressed service members stationed at Al Udeid Air Base, promising a pay raise and lauding the military's achievements.
What Happened: Citing the GOP Bill, which includes an extra <a href="https://www.benzinga.com/markets/equities/25/05/45217098/trumps-big-beautiful-bill-takes-shape-gop-pushes-tax-cuts-border-wall-funding-and-deep-spending-reductions-ahead-of-memorial-day-deadline">$150 billion for military spending</a>, Trump said, "My 2026 budget includes across the board – maybe you don&#8217;t want to look for the good of the country, you don&#8217;t have to take it – pay raises for each and every one of you. Substantial pay raises." 
He then called the U.S. military "without a doubt the greatest fighting force in the history of the world."
Referring to America&#8217;s cutting-edge defense capabilities, he said, "We have the strongest military in the world. It&#8217;s not even a contest. We have the best equipment, nobody has equipment like us, nobody has the planes or the missiles or anything else." He added, "As your commander-in-chief, I&#8217;m here to say that America&#8217;s military will soon be bigger, better, stronger and more powerful than ever."
According <a href="https://www.foxnews.com/politics/trump-promises-pay-raise-troops-touts-military-reforms-qatar-speech">to</a> Fox News, he also criticized former President Joe Biden's handling of the Afghanistan exit and mentioned the U.S. service members who were martyred during the Kabul evacuation.
See Also: <a href="https://www.benzinga.com/general/health-care/25/05/45435914/bernie-sanders-calls-trumps-big-beautiful-bill-a-death-sentence-says-it-delivers-235-billion-tax-break-to-top-0-2-while-99-8-of-americans-get-not">Bernie Sanders Calls Trump&#8217;s &#8216;Big Beautiful Bill&#8217; A &#8216;Death Sentence,&#8217; Says It Delivers $235 Billion Tax Break To Top 0.2%—While 99.8% Of Americans Get Nothing</a>
Why It Matters: The Al Udeid Air Base, where Trump made these statements, is one of the U.S.&#8217;s largest Middle Eastern bases and a strategic center for U.S. Central Command operations. The speech to the troops came a day after his meeting with Qatar's Emir Sheikh Tamim bin Hamad Al Thani in Doha, finalizing a <a href="https://www.benzinga.com/government/regulations/25/05/45446924/trump-secures-12-trillion-qatar-deal-as-boeing-ge-land-record-orders">$1.2 trillion economic agreement</a> on major commitments across aviation, defense, energy, and technology sectors, including a "historic" $96 billion deal with Boeing. This came after a separate <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45390422/trump-unveils-historic-and-transformative-600-billion-saudi-deal-predicts-markets-will-go-a-lot-higher">$600 billion investment pledge</a> the administration secured in Saudi Arabia.
Trump's statements about a "bigger" military are in contrast with remarks he made in February, when he said, "there&#8217;s <a href="https://www.benzinga.com/news/25/02/43980072/theres-no-reason-to-spend-1-trillion-on-the-military-trumps-statement-sends-us-defense-stocks-spiraling-whil">no reason for us to be spending almost $1 trillion</a> on the military". Last month, however, reports emerged of a <a href="https://www.benzinga.com/25/05/45164029/pentagon-unveils-36-billion-army-overhaul-with-1000-drones-per-division-to-counter-rising-threats-from-china-and-russia">$36 billion plan</a> to reshape the Army&#8217;s structure, workforce, and acquisition systems.
These developments come on the heels of a SIRI study revealing that in 2024, <a href="https://www.benzinga.com/25/04/45032800/global-defense-budgets-surge-to-27-trillion-as-europe-and-middle-east-lead-steepest-increase-since-cold-war-report">U.S. military expenditure touched $997 billion</a>, making up 66% of NATO's total and 37% of global defense spending, which reached $2.7 trillion.
Read Next: <a href="https://www.benzinga.com/general/travel/25/05/45427289/peter-schiff-warns-qatars-200-billion-boeing-deal-could-spike-us-inflation-interest-rates-says-treasury-sell-off-may-follow">Peter Schiff Warns Qatar&#8217;s $200 Billion Boeing Deal Could Spike US Inflation, Interest Rates — Says Treasury Sell-Off May Follow</a>
Image Via Shutterstock

General

Trump Hails US Troops As The 'Greatest Fighting Force In The History Of The World,' Promises Pay Raises: 'America's Military Will Soon Be Bigger, Better, Stronger And More Powerful Than Ever'

Total passenger traffic up 14.0% YoY, up 16.4% YoY in Argentina
International passenger traffic up 14.1% YoY; up 21.1% YoY in Argentina
Corporación América Airports S.A. (NYSE:<a href="https://www.benzinga.com/stock/CAAP#NYSE">CAAP</a>), ("CAAP" or the "Company"), one of the leading private airport operators in the world, reported today a 14.0% year-on-year (YoY) increase in passenger traffic in April 2025.

CAAP

Corporación América Airports April 2025 Passenger Traffic Up 14.0% YoY

WestPark Capital analyst Casey Ryan reiterates Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) with a Buy and maintains $4.62 price target.

Reiteration

BLIN

WestPark Capital Reiterates Buy on Bridgeline Digital, Maintains $4.62 Price Target

Canaccord Genuity analyst Whitney Ijem maintains Palvella Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PVLA#NASDAQ">PVLA</a>) with a Buy and lowers the price target from $53 to $52.

PVLA

Canaccord Genuity Maintains Buy on Palvella Therapeutics, Lowers Price Target to $52

WestPark Capital analyst Casey Ryan reiterates Ideal Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPWR#NASDAQ">IPWR</a>) from Hold to Hold.

IPWR

WestPark Capital Reiterates Hold on Ideal Powerto Hold

Canaccord Genuity analyst Maria Ripps maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Buy and raises the price target from $1200 to $1380.

NFLX

Canaccord Genuity Maintains Buy on Netflix, Raises Price Target to $1380

Canaccord Genuity analyst Maria Ripps maintains Fluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNT#NASDAQ">FLNT</a>) with a Hold and lowers the price target from $3.5 to $3.

FLNT

Canaccord Genuity Maintains Hold on Fluent, Lowers Price Target to $3

TD Securities analyst Andrew Charles reiterates Cava Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) with a Buy and maintains $120 price target.

CAVA

TD Securities Reiterates Buy on Cava Group, Maintains $120 Price Target

NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/NB#NASDAQ">NB</a>) is pleased to announce that it has received a preliminary, non-binding Expression of Interest (the "EOI") from UKEF, for a potential debt guarantee of up to $200 million to help finance construction of NioCorp's proposed Elk Creek Critical Minerals Project (the "Elk CreekProject").
While only an EOI, any eventual loan guarantee from UKEF to NioCorp would be contingent upon NioCorp meeting certain conditions, including among other matters execution of an offtake agreement for one or more of NioCorp's planned products to UK-based companies that in turn can be shown to support UK exports. NioCorp is engaged in discussions with UK-based exporters on the potential sale of scandium-based products from the Elk Creek Project.
Any debt guarantee issued by UKEF would be coordinated with prospective debt financing from EXIM, and any prospective loan guarantee from the German Government's Untied Loan Guarantee Loan Program, for which NioCorp has previously been deemed eligible to receive. UKEF's engagement with the Elk Creek Project is at an early stage. The LOI is not a legally binding commitment and is subject to a series of standard project finance terms and due diligence as per UKEF policies.

NioCorp Developments Receives Preliminary, Non-binding EOI From UKEF, For Potential Debt Guarantee Of Up To $200M To Help Finance Construction Of NioCorp's Proposed Elk CreekProject

Home Depot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) will release its first-quarter earnings results before the opening <a href="https://www.benzinga.com/quote/HD/earnings">bell on Tuesday, May 20.</a>
Analysts expect the Atlanta, Georgia-based company to report quarterly earnings at $3.59 per share. That&#8217;s down from $3.63 per share in the year-ago period. According to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, Home Depot projects to report quarterly revenue at $39.14 billion, compared to $36.42 billion a year earlier.
On May 8, Wells Fargo analyst Zachary Fadem maintained Home Depot with an Overweight rating and lowered the price target from $445 to $420.
With the recent buzz around Home Depot, some investors may be eyeing potential gains from the company's dividends. Currently, Home Depot offers an annual dividend yield of 2.43%. Its quarterly dividend is $2.30 per share ($9.20 a year).  
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $246,676 or around 652 shares. For a more modest $100 per month or $1,200 per year, you would need $49,222 or around 130 shares.
See Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38159876/citizens-and-2-other-stocks-under-3-insiders-are-buying">Citizens And 2 Other Stocks Under $3 Insiders Are Buying</a>
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($9.20 in this case). So, $6,000 / $9.20 = 652 ($500 per month), and $1,200 / $9.20 = 130 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
HD Price Action: Shares of Home Depot gained 1.6% to close at $378.63 on Thursday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>
Image: Shutterstock

Earnings

Long Ideas

Markets

Trading Ideas

How To Earn $500 A Month From Home Depot Stock Ahead Of Q1 Earnings

Canaccord Genuity analyst Richard Close maintains Doximity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) with a Hold and lowers the price target from $71 to $50.

DOCS

Canaccord Genuity Maintains Hold on Doximity, Lowers Price Target to $50

Canaccord Genuity analyst George Gianarikas maintains Dragonfly Energy Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) with a Buy and lowers the price target from $3 to $1.5.

DFLI

Canaccord Genuity Maintains Buy on Dragonfly Energy Hldgs, Lowers Price Target to $1.5

Cenntro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENN#NASDAQ">CENN</a>) reported quarterly losses of $(0.17) per share. This is a 32 percent increase over losses of $(0.25) per share from the same period last year. The company reported $2.14 million in sales this quarter. This is a 8.54 percent decrease over sales of $2.34 million the same period last year.

CENN

Cenntro Q1 EPS $(0.17) Up From $(0.25) YoY, Sales $2.14M Down From $2.34M YoY

Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) shares fell on Friday after the company announced that CEO Lars Fruergaard Jørgensen will <a target="_blank" href="https://view.news.eu.nasdaq.com/view?id=b6731bc5fbbb86a53bdd454ea6c2f7d98&amp;lang=en&amp;src=listed" rel="noreferrer noopener">step down</a> after eight years leading the company.
He will remain in the role temporarily to help ensure a smooth leadership transition while a successor is identified.
The decision follows a decline in Novo Nordisk's share price since mid-2024 and increased pressure from the Novo Nordisk Foundation, which holds majority voting power through its investment company. The foundation also pushed for stronger board representation.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/05/45418556/novo-nordisks-ozempic-weight-loss-jabs-could-boost-uk-economy-by-6-billion-study-finds" rel="noreferrer noopener">Novo Nordisk's Ozempic Weight Loss Jabs Could Boost UK Economy By $6 Billion, Study Finds</a>
NVO stock has lost close to 50% of its value in the last year and is down over 23% year-to-date. The company makes blockbuster drugs like Ozempic and Wegovy.
The company said that during his eight years as CEO, Novo Nordisk's sales, profits and share price have almost tripled.
Helge Lund, chair of the Novo Nordisk Board, says, "Novo Nordisk's strategy remains unchanged, and the Board is confident in the company's current business plans and its ability to execute on the plans."
Lars Rebien Sørensen, current chair of the foundation and former CEO of Novo Nordisk, will join the company's board as an observer.
He is expected to be nominated as a board member at the 2026 Annual General Meeting, bringing with him extensive industry experience and deep company knowledge. Board Chair Helge Lund said the company's overall strategy remains intact.
The executive transition comes amid mixed business signals. While the company reported lukewarm <a target="_blank" href="https://www.benzinga.com/25/05/45252150/novo-nordisk-expects-fda-decision-for-oral-wegovy-by-end-of-2025-reports-mixed-q1-earnings" rel="noreferrer noopener">Q1 earnings</a>, it remains optimistic about upcoming regulatory milestones, including an expected FDA decision on oral Wegovy by the end of 2025.
On Wednesday, Novo Nordisk entered a global <a target="_blank" href="https://www.benzinga.com/general/biotech/25/05/45407486/novo-nordisk-inks-22-billion-deal-with-septerna-to-develop-oral-weight-loss-and-diabetes-drugs" rel="noreferrer noopener">collaboration</a> with Septerna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) to develop oral small-molecule therapies for obesity, type 2 diabetes, and cardiometabolic diseases.
The deal includes over $200 million in upfront and near-term milestone payments, with Septerna eligible for up to $2.2 billion in total. Novo Nordisk will cover all development costs and lead commercialization.
Price Action: NVO shares are trading lower by 3.87% to $63.64 premarket at the last check on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com//node/45347237" target="_blank" rel="noreferrer noopener">Novo Nordisk's Sogroya Supports Effective Weekly Alternative To Daily Hormone Therapy Across Three Growth Disorders</a></li>
</ul>
Photo by KK Stock via Shutterstock

Management

Movers

SEPN

Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role

One-Year Data Show Lasting Reductions in Glucocorticoid Doses and Improvements in Clinical Outcomes with CRENESSITY&#x2122; (crinecerfont) in Pediatric Patients with Classic Congenital Adrenal Hyperplasia
SAN DIEGO, May 16, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4429374-1&amp;h=3224598362&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc.">Neurocrine Biosciences, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) today announced&nbsp;it will present new data from the Phase 3 CAHtalyst&#x2122; Pediatric study showing lasting reductions in&nbsp;glucocorticoid doses in pediatric patients with classic congenital adrenal hyperplasia who received <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4429374-1&amp;h=3320559394&amp;u=https%3A%2F%2Fwww.crenessity.com%2F&amp;a=CRENESSITY%E2%84%A2+(crinecerfont)">CRENESSITY&#x2122; (crinecerfont)</a>&nbsp;for up to one year. In addition, the study showed that for patients on CRENESSITY, adrenocorticotropic hormone, 17-hydroxyprogesterone and androstenedione remained below baseline levels, despite substantially decreased glucocorticoid doses. Results also showed improvements in clinical outcomes, including body mass index and insulin resistance. These data will be presented at the Pediatric Endocrine Society (PES) 2025 Annual Meeting&nbsp;taking place from May 15-18, 2025, in National Harbor, MD. &nbsp;

NBIX

Neurocrine Biosciences To Present One-Year Data From Phase 3 CAHtalyst Pediatric Study At PES 2025, Showing Lasting Reductions In Glucocorticoid Doses Who Received CRENESSITY

Small Cap Consumer Research analyst Eric Beder reiterates Lands' End (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LE#NASDAQ">LE</a>) with a Buy and maintains $20 price target.

Small Cap Consumer Research Reiterates Buy on Lands' End, Maintains $20 Price Target

Press Releases

CNFinance Announces Expansion of Share Repurchase Program

Real Estate

CNFinance to Report the First Half of 2024 Financial Results on Tuesday, August 27, 2024

CNFinance Announces First Half of 2024 Unaudited Financial Results

Fintech

CNFinance to Hold an Extraordinary General Meeting on November 29, 2024

CNFinance Announces Change of Name and the Results of its Extraordinary General Meeting

CNFinance Announces Change of Auditor

Statement from CNFinance Holdings Limited

CNFinance Holdings Limited Announces Receipt of NYSE Notification Regarding ADS Trading Price Requirement

CNFinance Files Annual Report on Form 20-F for Fiscal Year 2024

CNFinance to Hold Annual General Meeting on May 29, 2025

Enact Holdings

Federal Agricultural Mortgage Corporation Common Stock

Federal Agricultural

Better Home & Finance Holding Company - Class A Common Stock

Better Home & Finance

Mr. Cooper Gr

Essent Group

Finance of America Companies Inc. Class A Common Stock

Finance of America

Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Comments

CNFinance Hldgs

CNFinance Hldgs (CNF) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL